Veradigm Inc.
MDRX Healthcare Health Information Services
Follow MDRX
Veradigm Inc. (MDRX) EV/Sales
As of 16 October 2026, Veradigm Inc. (MDRX) trades at a EV/Sales of 0.6×. Over the past ten years it has ranged from −17.8× (December 2021) to 34.5× (June 2021); the current reading is higher than 15% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2024 | 1.5× | (11.14%) |
| FY2023 | 1.7× | (41.90%) |
| FY2022 | 2.9× | (36.21%) |
| FY2021 | 4.6× | 29.71% |
| FY2020 | 3.6× | 140.90% |
| FY2019 | 1.5× | 9.60% |
| FY2018 | 1.3× | (42.58%) |
| FY2017 | 2.3× | (0.25%) |
| FY2016 | 2.4× | (2.79%) |
| FY2015 | 2.4× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Dec 2022 | 2.9× | 23.92% |
| Sep 2022 | 2.4× | (1.74%) |
| Jun 2022 | 2.4× | (51.95%) |
| Mar 2022 | 5.0× | 9.03% |
| 28 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDRX Veradigm Inc. | 0.6× |
| EVH Evolent Health, Inc compare | 0.6× |
| TDOC Teladoc Health, Inc. compare | 0.9× |
| PHR Phreesia, Inc. compare | 1.5× |
| WEAV Weave Communications, Inc. compare | 2.0× |
| HSTM HealthStream, Inc. compare | 2.9× |
| NRC National Research Corporation compare | 3.8× |
| CTEV Claritev Corporation compare | 5.0× |
| SOPH SOPHiA GENETICS SA compare | 5.1× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)